About Us
Microsize was created out of a growing demand for solubility and bioavailability enhancements utilizing technologies that can accelerate speed-to-market. Microsize is the largest, independent, US-based CDMO specializing in micronization and particle size control. Microsize provides the “first choice” technology for improving bioavailability of poorly soluble APIs (including HPAPI’s) via micronization.
With nearly three decades of expertise, and experience gained in over 10,000 production campaigns, 100s of APIs processed, and continuous investments in technology and facilities, Microsize provides clients the best combination of capabilities and expertise to speed your molecule-to-market. While our most exciting chapter lies ahead, Microsize prides itself today as a highly differentiated organization bringing the best of both worlds: providing the high customer-touch, flexibility and nimbleness of a smaller organization, COMBINED WITH the world-class facilities, quality systems, and capabilities you’d come to expect from a larger global CDMO. When it comes to your toughest micronization challenges, Think Microsize.